Literature DB >> 23821356

An ipsilateral comparison of acceleromyography and electromyography during recovery from nondepolarizing neuromuscular block under general anesthesia in humans.

Sophie S Liang1, Paul A Stewart, Stephanie Phillips.   

Abstract

BACKGROUND: Residual neuromuscular block is defined as a mechanomyography (MMG) or electromyography (EMG) train-of-four (TOF) ratio <0.90, and is common in patients receiving neuromuscular blocking drugs. Objective neuromuscular monitoring is the only reliable way to detect and exclude residual neuromuscular block. Acceleromyography (AMG) is commercially available and easy to use in the clinical setting. However, AMG is not interchangeable with MMG or EMG. Currently, it is unclear what value must be reached by AMG TOF ratio to reliably exclude residual neuromuscular block.
METHODS: During spontaneous recovery from neuromuscular block, we monitored TOF ratio on the same arm using AMG at the adductor pollicis and EMG at the first dorsal interosseus. AMG and EMG TOF ratios were compared by the Bland-Altman analysis for repeated measurements. The precision of each device was assessed by the repeatability coefficient. A small repeatability coefficient indicates high precision of the device. The agreement between the devices was assessed by the bias and the 95% limits of agreement. Small bias and narrow limits of agreement indicate strong agreement. We defined clinically acceptable agreement between AMG and EMG as a bias <0.025 and limits of agreement within -0.050 to 0.050, provided that the control comparison between EMG and itself can fulfill these criteria.
RESULTS: In 26 patients, 261 comparisons between AMG and EMG were made. The repeatability coefficient of AMG and EMG were 0.094 (95% confidence interval [CI], 0.088-0.100) and 0.051 (95% CI, 0.048-0.055), respectively. The bias between AMG and EMG TOF ratio was 0.176 (95% CI, 0.162-0.190), with limits of agreement -0.045 to 0.396 (95% CI, -0.067 to 0.419).
CONCLUSIONS: AMG is less precise than EMG and overestimates EMG TOF ratio by at least 0.15. The lack of agreement cannot be attributed to instrumental imprecision or the baseline difference between successive measurements during spontaneous recovery of neuromuscular function. Residual neuromuscular block cannot be excluded on reaching an AMG TOF ratio of 1.00.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821356     DOI: 10.1213/ANE.0b013e3182937fc4

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

Review 1.  Neuromuscular monitoring: an update.

Authors:  Mădălina Duţu; Robert Ivaşcu; Oana Tudorache; Darius Morlova; Alina Stanca; Silvius Negoiţă; Dan Corneci
Journal:  Rom J Anaesth Intensive Care       Date:  2018-04

Review 2.  [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].

Authors:  C Unterbuchner; K Ehehalt; B Graf
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

Review 3.  The latest trend in neuromuscular monitoring: return of the electromyography.

Authors:  Wonjin Lee
Journal:  Anesth Pain Med (Seoul)       Date:  2021-04-12

4.  Synergism between rocuronium and cisatracurium: comparison of the Minto and Greco interaction models.

Authors:  Soeun Jeon; Jae Young Kwon; Hae-Kyu Kim; Tae Kyun Kim
Journal:  Korean J Anesthesiol       Date:  2016-06-22

5.  Development of an algorithm using clinical tests to avoid post-operative residual neuromuscular block.

Authors:  Christoph Unterbuchner; Manfred Blobner; Friedrich Pühringer; Matthias Janda; Sebastian Bischoff; Berthold Bein; Annette Schmidt; Kurt Ulm; Viktor Pithamitsis; Heidrun Fink
Journal:  BMC Anesthesiol       Date:  2017-08-04       Impact factor: 2.217

6.  A comparison of a prototype electromyograph vs. a mechanomyograph and an acceleromyograph for assessment of neuromuscular blockade.

Authors:  A Bowdle; L Bussey; K Michaelsen; S Jelacic; B Nair; K Togashi; J Hulvershorn
Journal:  Anaesthesia       Date:  2019-10-16       Impact factor: 6.955

7.  Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.

Authors:  Jay C Horrow; Manfred Blobner; Wen Li; John Lombard; Marcel Speek; Matthew DeAngelis; W Joseph Herring
Journal:  BMC Anesthesiol       Date:  2021-02-27       Impact factor: 2.217

8.  Comparison of clinical validation of acceleromyography and electromyography in children who were administered rocuronium during general anesthesia: a prospective double-blinded randomized study.

Authors:  Woojun Jung; Minho Hwang; Young Ju Won; Byung Gun Lim; Myoung-Hoon Kong; Il-Ok Lee
Journal:  Korean J Anesthesiol       Date:  2016-01-28

9.  Exploratory Outlier Detection for Acceleromyographic Neuromuscular Monitoring: Machine Learning Approach.

Authors:  Michaël Verdonck; Hugo Carvalho; Johan Berghmans; Patrice Forget; Jan Poelaert
Journal:  J Med Internet Res       Date:  2021-05-31       Impact factor: 5.428

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.